Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2014
03/26/2014CN103655620A Toad skin gel and preparation technology thereof
03/26/2014CN103655613A Application of arsenic trioxide and water-soluble object thereof in preparing medicine for treating pancreatic cancer
03/26/2014CN103655600A Drug composition for treating cancers, preparation method and applications
03/26/2014CN103655597A Novel application of curculigo polysaccharide and derivatives of curculigo polysaccharide
03/26/2014CN103655596A Application of CpG-ODN 7909 sequence to preparation of drug for relieving tumor cell radiation tolerance
03/26/2014CN103655591A Medicinal composition as well as preparation and application thereof
03/26/2014CN103655590A Pharmaceutical composition containing gentiopicroside and preparation and usage thereof
03/26/2014CN103655589A Pharmaceutical composition and preparation and usage thereof
03/26/2014CN103655588A Doxorubicin hydrochloride pharmaceutical composition and preparation method thereof
03/26/2014CN103655587A Dendrimer drug delivery system with high tumor recognition ability and environmental response drug release ability and building method thereof
03/26/2014CN103655582A Epoxide sterol composition, and preparation and application thereof
03/26/2014CN103655581A Application of bile acid series derivatives in anti-tumor metastasis drugs
03/26/2014CN103655573A Application of pyrazolopyrimidine compound in preparation of transcription inhibitor medicine
03/26/2014CN103655564A Method of inhibiting constitutively active phosphorylated FLT3 kinase
03/26/2014CN103655563A Method of inhibiting mutant C-KIT
03/26/2014CN103655559A Application of incarvillateine compounds in preparation of anti-breast cancer drugs
03/26/2014CN103655552A Application of Manzamenone O in pancreas cancer treatment medicines
03/26/2014CN103655547A Novel application of scutellarein
03/26/2014CN103655527A Application of quinines compound used for preventing Wnt/[beta]-catenin signal purpose of melanoma cell
03/26/2014CN103655526A Novel application of gossypol
03/26/2014CN103655519A Curcumin solid lipid nanoparticle with P-gp inhibiting effect and preparation method thereof
03/26/2014CN103655518A 10-hydroxycamptothecine nano-micelles for injection and preparation method thereof
03/26/2014CN103655517A Pep-1 peptide modified gliomas targeted nano drug delivery system and preparation method thereof
03/26/2014CN103655513A Letrozole pharmaceutical composition and preparation method thereof
03/26/2014CN103655491A Irinotecan hydrochloride pharmaceutical composition and preparation method thereof
03/26/2014CN103655490A Idarubicin hydrochloride pharmaceutical composition and preparation method thereof
03/26/2014CN103655489A Epirubicin hydrochloride pharmaceutical composition and preparation method thereof
03/26/2014CN103655484A Method for preparing paclitaxel sustained-release microspheres by use of self-assembly technology and product thereof
03/26/2014CN103655475A Targeted liposomes
03/26/2014CN103655474A Compound drug-carrying liposome as well as preparation method and application thereof
03/26/2014CN103655471A Formula of liver targeting demehylcantharidin esterified derivative submicron emulsion injection and preparation method
03/26/2014CN103655452A Gene medicine delivery system and preparation method
03/26/2014CN103652926A Food composition for tumor patients
03/26/2014CN103652924A Compound grape seed oil soft capsule and preparation method for compound grape seed oil soft capsule
03/26/2014CN103652891A Lactobacillus casei embedding microcapsule and preparation method thereof
03/26/2014CN103652837A Cell wall broken Ganoderma Lucidum spore powder-Perilla herb oil composite softgel and preparation technology thereof
03/26/2014CN103191191B Preparation method of traditional Chinese medicine composition for treating advanced non-small cell lung cancers
03/26/2014CN103145801B Anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide from MTA1 (Tumor Metastasis Associated Antigen 1) and application thereof
03/26/2014CN103102412B Humanized anti-nasopharyngeal-cancer LMP2A extracellular region antibody Fab and application thereof
03/26/2014CN103027897B Method for preparing monodispersity hydrophobic drug nanoparticles by template method
03/26/2014CN103007098B Composition with functions of accelerating generation of nitric oxide and improving immunity and containing arginine, ginseng and coix seeds
03/26/2014CN102961688B Traditional Chinese medicine decoction capable of reducing alpha fetoprotein and preventing and treating liver cancer
03/26/2014CN102920746B Worm grass and Chinese blister beetle composition, enteric preparation, and application and preparation thereof
03/26/2014CN102895414B Chinese herbal paste for treating superficial cancer
03/26/2014CN102847171B Gene medicine for treating liver cancer and preparation method and application thereof
03/26/2014CN102846556B 5-fluorouracil drug-loading microspheres and preparation method thereof
03/26/2014CN102824345B Irinotecan hydrochloride composition and preparation method thereof
03/26/2014CN102731458B Bi-isopentene coumarin, as well as preparation method and application thereof
03/26/2014CN102688200B Plant anti-cancer targeting nano-preparation, and preparation method thereof
03/26/2014CN102652827B Medicament for treating cancer and preparation method of medicament
03/26/2014CN102652792B Anti-cancer application of composition containing garlic oil, garlic total polysaccharide and garlic total saponin
03/26/2014CN102643326B 3,6-dihydroxyl-22(27)imino-4-furan sterene and preparation method and application thereof
03/26/2014CN102625797B Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
03/26/2014CN102614354B Anticancer oral liquid and preparation method thereof
03/26/2014CN102603561B Dehydroabietylamine derivatives and application thereof in preparation of antitumor drugs
03/26/2014CN102600426B Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof
03/26/2014CN102586323B Method for constructing, expressing and purifying targeted immune fusion protein
03/26/2014CN102584927B Class I triterpenoid, preparation method and application thereof
03/26/2014CN102584888B 2-carboxyl benzamido thiourea trimethyltin compound, preparation method and application
03/26/2014CN102532039B Application of 5-fluoropyrimidine-4(3H)-ketone compound in preparation of anti-tumor medicaments
03/26/2014CN102526591B Special effect Chinese herbal medicine composition for treating leukemia
03/26/2014CN102504013B Target chemical drug PADM against cancer metastasis and preparation method and use thereof
03/26/2014CN102504005B Compound with novel structure and preparation method and applications thereof
03/26/2014CN102391191B Piperazine di-thiocarboxylic acid ester derivative of 2,4-di-aminoquinazoline, as well as preparation method and anti-tumor application of the derivative
03/26/2014CN102351631B Alpha-pinene extracted from pine needle, its extraction method and application for resisting tumor
03/26/2014CN102327327B Method for preparing traditional Chinese medicine macleaya cordata extract by adopting membrane separation
03/26/2014CN102285977B 5-tert-butyl-3-aryl-4-(1,2,4-triazol-1-yl)isoxazolidin-5-ol and application thereof
03/26/2014CN102202737B Disubstituted 2,3-phthalazine hedgehog pathway antagonists
03/26/2014CN102188716B Macromolecule vinblastine conjugate adopting amino acids or oligopeptides as connexons
03/26/2014CN102131814B New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, process for preparing them, and application thereof in therapy as anticancer agents
03/26/2014CN102078600B Anti-cancer compound ganoderma composition, application thereof and pharmaceutical composition containing same
03/26/2014CN102065866B Combinations comprising methotrexate and DHODH inhibitors
03/26/2014CN102056905B Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
03/26/2014CN102015708B Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
03/26/2014CN101835902B Ultraconserved regions encoding NCRNAS
03/26/2014CN101821292B Combination therapy with type I and type II anti-cd20 antibodies
03/26/2014CN101768199B Polymorphs of abiraterone acetate and preparation method thereof
03/26/2014CN101426766B Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors
03/26/2014CA2812258A1 Method of inhibiting mutant c-kit
03/25/2014US8680239 Use of RGM and its modulators
03/25/2014US8680202 Cyclodextrin-based polymers for therapeutics delivery
03/25/2014US8680124 Treatment of cancers with acquired resistance to kit inhibitors
03/25/2014US8680108 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
03/25/2014US8680100 Sulfonylhydrazide compounds for treating proliferative disorders
03/25/2014US8680096 Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
03/25/2014US8680092 Nitrogenous heterocyclic compound and medicinal use thereof
03/25/2014US8680087 Macrocyclic amides, pharmaceutical compositions, preparation methods and uses thereof
03/25/2014US8680080 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
03/25/2014US8680068 Herpes virus strains
03/25/2014US8680043 Synthetic immunogenic glycoconjugate for melanoma immunotherapy
03/25/2014US8680041 Genetic variations associated with tumors
03/25/2014US8679830 Viral vectors
03/25/2014US8679810 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
03/25/2014US8679492 Humanized antibodies that bind to CD19 and their uses
03/25/2014US8679483 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
03/25/2014CA2789114C Medical compositions for intravesical treatment of bladder cancer
03/25/2014CA2735177C Saturated bicyclic heterocyclic derivatives as smo antagonists
03/25/2014CA2665428C Hdac inhibitors
03/25/2014CA2652633C Crystalline forms of gemcitabine amide prodrug, compositions and use thereof
03/25/2014CA2623879C Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 2211